企業プロフィール
Arcturus Therapeutics Holdings Inc. 株価・ニュース・カタリスト
- ティッカー:
- ARCT
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
8.14 USD (-1.09%)
終値
最終更新: 2026年8月17日
217M USD
時価総額
株価変動の要因
As of Aug 17, 2026, ARCT closed down 1.09% at $8.14. No new same-company headline was identified in the current news window.
企業概要
事業概要
Arcturus Therapeutics is an RNA medicines company focused on mRNA and self-amplifying RNA technologies. Its story is built around platform science that aims to produce vaccines and therapeutics across multiple disease areas.
所在地とセクター分類
Arcturus is headquartered in the United States and listed on NASDAQ. It sits in platform biotechnology with a strong RNA-technology identity.
ビジネスモデルの特徴
The company depends on platform validation, clinical progress, and the ability to convert RNA science into durable product revenue. Investors watch vaccine or therapeutic data, partnerships, and manufacturing capability.
バイオ業界での位置付け
Arcturus occupies a platform-RNA niche within biotech. It is sensitive to whether self-amplifying RNA can create differentiated therapeutic value beyond the first wave of products.
今後のカタリスト
- Arcturus’s catalysts are mRNA-platform updates, vaccine and therapeutic development, and any partnership or clinical step that keeps the platform credible. The company still needs human proof.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。